Commentary: Supporters argue that expanding access to blood-based tests would increase screening rates. Critics counter ...

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. It should be noted that the Galleri test not currently ...

The American Cancer Society updated its colorectal cancer screening guidelines May 27 to include new blood- and stool-based screening options, while making clear that the blood-based test is a last ...

The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older. The maker of the test, Palo Alto, California-based ...

The American Cancer Society updated colorectal cancer screening guidelines to include the FDA-approved Shield blood test for ...

The American Cancer Society has added blood tests every three years as a new option for colorectal cancer screening, in addition to colonoscopy and stool tests. While invasive, colonoscopy remains the ...

Broad endorsement for insurance-covered blood-based CRC screening (92%) suggests payer policy could materially influence uptake among guideline-eligible, average-risk adults starting at age 45.

Colorectal cancer is the third most diagnosed cancer in adults in the United States. Early detection could prevent more than 90% of colorectal cancer–related deaths, yet more than one third of the ...